Fig. 1
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12967-021-02842-1/MediaObjects/12967_2021_2842_Fig1_HTML.png)
a Progression free survival (PFS) and b Overall Survival (OS) in HER2-positive (n = 29) and HER2-negative (n = 40) gastric cancer patients. p-values were calculated using the log rank (Mantel–Cox) test with GraphPad Prism
a Progression free survival (PFS) and b Overall Survival (OS) in HER2-positive (n = 29) and HER2-negative (n = 40) gastric cancer patients. p-values were calculated using the log rank (Mantel–Cox) test with GraphPad Prism